Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients
- PMID: 25892898
- PMCID: PMC4394109
- DOI: 10.3748/wjg.v21.i14.4423
Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients
Abstract
Alcoholic liver disease (ALD) is the second most common diagnosis among patients undergoing liver transplantation (LT). The recovery results of patients transplanted for ALD are often at least as good as those of patients transplanted for other diagnoses and better than those suffering from hepatitis C virus, cryptogenic cirrhosis, or hepatocellular carcinoma. In the case of medically non-responding patients with severe acute alcoholic hepatitis or acute-on chronic liver failure, the refusal of LT is often based on the lack of the required alcohol abstinence period of six months. The obligatory abidance of a period of abstinence as a transplant eligibility requirement for medically non-responding patients seems unfair and inhumane, since the majority of these patients will not survive the six-month abstinence period. Data from various studies have challenged the 6-mo rule, while excellent survival results of LT have been observed in selected patients with severe alcoholic hepatitis not responding to medical therapy. Patients with severe advanced ALD should have legal access to LT. The mere lack of pre-LT abstinence should not be an obstacle for being listed.
Keywords: Abstinence; Alcohol; Alcoholic hepatitis; Cirrhosis; Liver transplantation; Six month abstinence rule.
Comment on
-
Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: an Italian position statement.World J Gastroenterol. 2014 Oct 28;20(40):14642-51. doi: 10.3748/wjg.v20.i40.14642. World J Gastroenterol. 2014. PMID: 25356027 Free PMC article. Review.
References
-
- Testino G, Burra P, Bonino F, Piani F, Sumberaz A, Peressutti R, Giannelli Castiglione A, Patussi V, Fanucchi T, Ancarani O, et al. Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: an Italian position statement. World J Gastroenterol. 2014;20:14642–14651. - PMC - PubMed
-
- Bendimerad P, Blecha L. [Benefits in reducing alcohol consumption: how nalmefene can help] Encephale. 2014;40:495–500. - PubMed
-
- Shearn CT, Petersen DR. Understanding the tumor suppressor PTEN in chronic alcoholism and hepatocellular carcinoma. Adv Exp Med Biol. 2015;815:173–184. - PubMed
-
- Donckier V, Lucidi V, Gustot T, Moreno C. Reply to: “liver transplantation and severe acute alcoholic hepatitis: an ethical consideration”. J Hepatol. 2014;61:707. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
